Amarin Corp Plc (AMRN)

[sstyles]

In light of GSK v. Teva, I am not convinced generics can just come in and take half of the CV market even if they had supply.

Amarin could still bring suit later on....and one would think market share would be some indication of direct infringement. Hard for a judge or jury to deny that half of the market share is the CV indication.